Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

granules

granules is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 3
Pipeline programs 47
News articles 0
Drug details — granules
Class
—
Route
—
Patents
3
Programs
47
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

granules is an FDA-listed pharmaceutical active ingredient.

Key facts

INN granules

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. AG348-C-020 Phase 3 · Anaxis Pharma · Anemia in subjects with sickle cell disease (SCD)
  2. D9612C09998 Phase 3 · AstraZeneca · Erosive Esophagitis
  3. GS-US-174-0144 Phase 3 · Gilead Sciences · Hepatitis B Infection
  4. Granules for oral suspension, N-Acetyl-L-Leucine Phase 3 · IntraBio · Niemann-Pick disease type C
  5. Jianpi Lishi Jiedu Granules Phase 3 · First People's Hospital · Colorectal Adenoma
  6. Lansoprazole microgranules suspension Phase 3 · Takeda · Gastroesophageal Reflux Disease
  7. MEX-DM-302 Phase 3 · Lupin (Europe) · Myotonic Dystrophy type 1 and type 2 (DM1/DM2)
  8. MEX-DM-303 Phase 3 · Lupin (Europe) · Myotonic Dystrophy type 1 and type 2 (DM1/DM2)

Related patents

Browse patents

  1. US 9011926

    Method for producing granules

    Expires Mon Apr 16 2035 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8871273

    Method for producing granules

    Expires Mon Oct 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8105626

    Granules containing acid-unstable chemical in large amount

    Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is granules?

granules is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.